Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04594811
Title NT-I7 in Combination With Nivolumab in Advanced Gastric, Gastro-Esophageal Junction or Esophageal Adenocarcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors NeoImmuneTech

esophagus adenocarcinoma

gastroesophageal junction adenocarcinoma

stomach carcinoma



Nivolumab + NT-I7

Age Groups: adult | senior
Covered Countries USA | ESP

No variant requirements are available.